Delivery Order SPE2DB22D3401-SPE2DB24FT4JK

Award Date 8/22/24
Potential Completion Date 8/23/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,804.18, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of May 1, 2024. The contract is not associated with any...
This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA). The prime contractor is AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $6,657.94 and an ultimate completion date of October 21, 2024. The contract is not set aside for any special designation. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with the...
The federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, through its Corporate Office division. The contract is a Delivery Order with a Firm Fixed Price of $4,240.09 and an ultimate completion date of April 23, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds two...
This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA). The contract, valued at $5,152.35, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is June 7, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the supply of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, the Corporate Office Division of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a Delivery Order with a Firm Fixed Price of $2,364.74 and a completion date of May 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,852.85, is a firm fixed-price delivery order with a completion date of July 26, 2022. The contract was awarded on July 25, 2022, and does not have a set-aside designation, indicating...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation, is for the delivery of lidocaine 5% patches. The $1,752.79 firm fixed price delivery order has an ultimate completion date of April 5, 2024. This award is not associated with any set-aside programs. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA,...
This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a Firm Fixed Price Delivery Order valued at $1,021.06. The contract has an ultimate completion date of August 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Lidocaine 5% Patches to support federal healthcare programs. The $2,732.06 contract has an ultimate completion date of July 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a broad range of medical commodities to military treatment facilities...
This federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price type, valued at $7,192.91, and has an ultimate completion date of October 13, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB24FT4JK
    Delivery Order

The federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that provides a wide range of medical supplies and prescription drugs to federal agencies. The contract is a Delivery Order with a Firm Fixed Price of $2,577.07 and an ultimate completion date of August 23, 2024. This award is not associated with a set-aside. Amerisourcebergen has multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to hundreds of millions of dollars, that enable the company to efficiently supply critical pharmaceutical and medical products to support various government healthcare programs and facilities.

Generated 11/21/24, 9:35 AM